Edition:
United States

Zhejiang Medicine Co Ltd (600216.SS)

600216.SS on Shanghai Stock Exchange

9.11CNY
15 Nov 2018
Change (% chg)

¥0.07 (+0.77%)
Prev Close
¥9.04
Open
¥9.00
Day's High
¥9.11
Day's Low
¥8.98
Volume
14,889,408
Avg. Vol
18,425,712
52-wk High
¥18.05
52-wk Low
¥7.81

Latest Key Developments (Source: Significant Developments)

Zhejiang Medicine Says 9-Month Net Profit Up 291.4 Percent Y/Y
Tuesday, 23 Oct 2018 06:59am EDT 

Oct 23 (Reuters) - Zhejiang Medicine Co Ltd <600216.SS>::SAYS 9-MONTH NET PROFIT UP 291.4 PERCENT Y/Y.  Full Article

Zhejiang Medicine to pay 2017 A shares dividend on July 19
Thursday, 12 Jul 2018 07:35am EDT 

July 12(Reuters) - Zhejiang Medicine Co Ltd <600216.SS>:Says it will pay a cash dividend of 0.08 yuan per share (before tax) for 2017, to shareholders of A shares recorded on July 18.Says the company's shares will be traded ex-right and ex-dividend on July 19 and the dividend will be paid on July 19 .  Full Article

Zhejiang Medicine Says Board Elects Li Chunbo As Chairman
Friday, 15 Jun 2018 06:54am EDT 

June 15 (Reuters) - Zhejiang Medicine Co Ltd <600216.SS>::SAYS BOARD ELECTS LI CHUNBO AS CHAIRMAN.  Full Article

Zhejiang Medicine passes review of high-tech enterprise recognition
Thursday, 21 Dec 2017 10:28pm EST 

Dec 22 (Reuters) - Zhejiang Medicine Co Ltd <600216.SS> ::Says it passed the review of high-tech enterprise recognition and will enjoy a tax preference of 15 percent for three years.  Full Article

Zhejiang Medicine terminates clinical trial for a kind of antitumor drug
Thursday, 21 Dec 2017 10:25pm EST 

Dec 22 (Reuters) - Zhejiang Medicine Co Ltd <600216.SS> ::Says it decided to terminate clinical trials for a kind of antitumor drug (R&D code name of XC302).  Full Article

Zhejiang Medicine's 9-month net profit down 67.55 pct y/y
Sunday, 22 Oct 2017 07:55am EDT 

Oct 22 (Reuters) - Zhejiang Medicine Co Ltd <600216.SS>:Says its 9-month net profit down 67.55 percent y/y from 405 million yuan ($61.19 million) a year ago.  Full Article